Prognostic value of ESR2 expression on adjuvant chemotherapy in completely resected NSCLC

BACKGROUND: Prognostic biomarker, which can inform the treatment outcome of adjuvant chemotherapy (ACT) after complete resection of early-stage non-small cell lung cancer (NSCLC), is urgently needed for the personalized treatment of these patients. PATIENTS AND METHODS: The prognostic value of gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Hongliang, Gu, Dayong, Qian, Pudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746143/
https://www.ncbi.nlm.nih.gov/pubmed/33332474
http://dx.doi.org/10.1371/journal.pone.0243891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746143/
https://www.ncbi.nlm.nih.gov/pubmed/33332474
http://dx.doi.org/10.1371/journal.pone.0243891

Ejemplares similares